Our results indicate that as lesions progress from low to high grade to cancer, there is an increase in cytokine production, for instance G-CSF, which causes systemic effects that influence the triggering of adaptive immune responses, partially inhibiting antigen presentation and therefore T cell activation. This evidence concerns the gene CSF3 and cancer.